Across TCGA pan-cancer cohorts, OR2J1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR2J1 data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher OR2J1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR2J1 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.
BRCA, KIRC, and THCA are the cancer types where OR2J1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.